Ушбу ишга иқтибос қилган ишлар

4 та иш

Иш: Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

1. Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

   Yang He, Yuefei Fang, Meng Zhang +7

   МақолаHistone Deacetylase Inhibitors ResearchActa Pharmaceutica Sinica B20214 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000056

2. Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer

   Yonghui Wang, Binfan Chen, Zhidi He +7

   МақолаHistone Deacetylase Inhibitors ResearchNanoscale20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000556

3. Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment

   Rong Wang, Jingkun Qu, Xueping Tang +7

   МақолаImmune cells in cancerMolecular Pharmaceutics20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.000496

4. Nanotechnology-based shikonin delivery strategies for modulating the tumor immune microenvironment efficacy

   Dipika Ramdas Kalambhe, Akmal M. Asrorov, Nurkhodja Mukhammedov +3

   Шарҳ мақолаBioactive Compounds and Antitumor AgentsDrug Delivery and Translational Research20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000221